Drug Shortage Report for TAMSULOSIN CR
Report ID | 28095 |
Drug Identification Number | 02429667 |
Brand name | TAMSULOSIN CR |
Common or Proper name | TAMSULOSIN CR |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | TAMSULOSIN HYDROCHLORIDE |
Strength(s) | 0.4MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 500 |
ATC code | G04CA |
ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-01-04 |
Actual start date | |
Estimated end date | 2018-01-12 |
Actual end date | 2017-12-29 |
Shortage status | Avoided shortage |
Updated date | 2018-01-18 |
Company comments | Other pack size available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2018-01-18 | French | Compare |
v7 | 2018-01-18 | English | Compare |
v6 | 2017-12-26 | English | Compare |
v5 | 2017-12-12 | French | Compare |
v4 | 2017-12-12 | English | Compare |
v3 | 2017-11-21 | English | Compare |
v2 | 2017-11-05 | French | Compare |
v1 | 2017-11-05 | English | Compare |
Showing 1 to 8 of 8